TC Biopharm ()

AI Score

0

Unlock

0.01
-0.00 (-32.43%)
At close: Mar 03, 2025, 3:57 PM
0.01
0.00%
After-hours: Mar 03, 2025, 03:57 PM EST

TC Biopharm () Statistics

Share Statistics

TC Biopharm () has 26.48K shares outstanding. The number of shares has increased by 1270.77% in one year.

Shares Outstanding 26.48K
Shares Change (YoY) 1270.77%
Shares Change (QoQ) -50.89%
Owned by Institutions (%) 2.47%
Shares Floating 98.45M
Failed to Deliver (FTD) Shares 1.35K
FTD / Avg. Volume 3.02%

Short Selling Information

The latest short interest is 0, so 0% of the outstanding shares have been sold short.

Short Interest 0
Short % of Shares Out 0%
Short % of Float 0%
Short Ratio (days to cover) 0

Valuation Ratios

The PE ratio is -41.71 and the forward PE ratio is null. TC Biopharm ()'s PEG ratio is 0.83.

PE Ratio -41.71
Forward PE n/a
PS Ratio 0
Forward PS null
PB Ratio 91.76
P/FCF Ratio -23.12
PEG Ratio 0.83
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for TC Biopharm ().

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.2, with a Debt / Equity ratio of 0.67.

Current Ratio 1.2
Quick Ratio 1.2
Debt / Equity 0.67
Total Debt / Capitalization 40.15
Cash Flow / Debt -5.85
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -2.2% and return on capital (ROIC) is -267.99%.

Return on Equity (ROE) -2.2%
Return on Assets (ROA) -0.66%
Return on Capital (ROIC) -267.99%
Revenue Per Employee $0
Profits Per Employee $-144,072.02
Employee Count 41
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -1.09M
Effective Tax Rate 0.16

Stock Price Statistics

The stock price has increased by -47.09% in the last 52 weeks. The beta is 0.01, so TC Biopharm ()'s price volatility has been higher than the market average.

Beta 0.01
52-Week Price Change -47.09%
50-Day Moving Average 0.01
200-Day Moving Average 0.02
Relative Strength Index (RSI) 46.41
Average Volume (20 Days) 44.7K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -14.24M
Net Income -5.91M
EBITDA -13.61M
EBIT n/a
Earnings Per Share (EPS) -0.05
Full Income Statement

Balance Sheet

The company has 2.46M in cash and 1.8M in debt, giving a net cash position of 661.45K.

Cash & Cash Equivalents 2.46M
Total Debt 1.8M
Net Cash 661.45K
Retained Earnings -38.84M
Total Assets 6.87M
Working Capital 423.86K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.54M and capital expenditures -110.35K, giving a free cash flow of -10.66M.

Operating Cash Flow -10.54M
Capital Expenditures -110.35K
Free Cash Flow -10.66M
FCF Per Share -0.09
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TCBPW does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -500%
FCF Yield -22099.39%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for TCBPW.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Nov 21, 2022. It was a backward split with a ratio of 1:50.

Last Split Date Nov 21, 2022
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score -14.7
Piotroski F-Score 3